ascendis pharma glp-1 receptor agonist Understanding agonists and their impact on drug discovery ascendis pharma glp-1 receptor agonist

Explore the main brands, common side effects, long term effects and key FAQs.

Peptide agonists of the glucagon-like peptide-1 receptor (GLP-1R) have revolutionized diabetes therapy, but their use has been limited by the requirement for injection

Side Effects: As a GLP-1 therapy, common side effects are typically gastrointestinal, including nausea, vomiting, and diarrhea.

Specifically, the trial reported an average weight loss of 17.5% and 24.4% at 24 and 48 weeks, respectively

Traditionally, Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs), a pivotal class of drug, mimics the actions of endogenous Glucagon-like peptide-...